Polymer Capital Management’s BioAge Labs BIOA Stock Holding History
Bought
Maintained
Sold
Other funds holding BIOA
ACM
CAM
SI
JT
OCA
RCM
MB
PCH
Polymer Capital Management's BIOA Position: Q2 2026 in Review
Polymer Capital Management sold out of BioAge Labs (BIOA) in Q2 2026, closing a stake of 11,688 shares — an estimated $204K sold.
Polymer Capital Management first reported a position in BIOA in Q1 2026 and held it in 1 quarter. The position peaked at $204K in Q1 2026. 151 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.
- Polymer Capital Management reported no remaining BioAge Labs position as of Q2 2026 after selling out during the quarter.
- Polymer Capital Management sold 11,688 BioAge Labs shares in Q2 2026, an estimated $204K.
- Polymer Capital Management first reported a position in BioAge Labs in Q1 2026 and held it in 1 quarter.
- Polymer Capital Management's BioAge Labs position peaked at $204K in Q1 2026.
- 151 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.
Based on Polymer Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.